US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 7.150
  • +0.090+1.27%
Trading Dec 16 13:05 ET
222.62MMarket Cap-2.69P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
55.79%25.14M
38.13%21.44M
22.75%17.67M
105.48%67.1M
111.69%21.05M
68.53%16.14M
161.94%15.52M
99.57%14.39M
101.79%32.66M
132.90%9.95M
Selling and administrative expenses
6.92%6.28M
28.27%6.41M
33.66%6.2M
142.06%21.08M
36.54%5.58M
259.46%5.87M
170.51%5M
305.16%4.64M
253.12%8.71M
235.50%4.08M
-General and administrative expense
6.92%6.28M
28.27%6.41M
33.66%6.2M
142.06%21.08M
36.54%5.58M
259.46%5.87M
170.51%5M
305.16%4.64M
253.12%8.71M
235.50%4.08M
Research and development costs
83.73%18.86M
42.81%15.03M
17.58%11.47M
92.18%46.02M
164.04%15.48M
29.27%10.27M
158.06%10.52M
60.81%9.76M
74.58%23.95M
92.01%5.86M
Operating profit
-55.79%-25.14M
-38.13%-21.44M
-22.75%-17.67M
-105.48%-67.1M
-111.69%-21.05M
-68.53%-16.14M
-161.94%-15.52M
-99.57%-14.39M
-101.79%-32.66M
-132.90%-9.95M
Net non-operating interest income expense
52.60%2.7M
52.20%2.69M
-19.98%1.45M
1.77M
1.77M
1.81M
Non-operating interest income
52.60%2.7M
52.20%2.69M
-19.98%1.45M
----
----
--1.77M
--1.77M
--1.81M
----
----
Other net income (expense)
101.03%1K
66.46%-55K
-55.29%-264K
350.67%6.72M
603.35%7.15M
-125.73%-97K
-256.19%-164K
-2,025.00%-170K
2,625.42%1.49M
1,491.78%1.02M
Other non- operating income (expenses)
101.03%1K
66.46%-55K
-55.29%-264K
350.67%6.72M
603.35%7.15M
-125.73%-97K
-256.19%-164K
-2,025.00%-170K
2,625.42%1.49M
1,491.78%1.02M
Income before tax
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
Income tax
Net income
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
Net income continuous Operations
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
Minority interest income
Net income attributable to the parent company
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
Basic earnings per share
10.61%-0.59
17.46%-0.52
-25.86%-0.73
63.76%-2.74
-8.75%-0.87
-34.97%-0.66
-39.75%-0.63
-3.71%-0.58
-500.86%-7.56
-137.81%-0.8
Diluted earnings per share
10.61%-0.59
17.46%-0.52
-25.86%-0.73
63.76%-2.74
-8.75%-0.87
-34.97%-0.66
-39.75%-0.63
-3.71%-0.58
-500.86%-7.56
-137.81%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 55.79%25.14M38.13%21.44M22.75%17.67M105.48%67.1M111.69%21.05M68.53%16.14M161.94%15.52M99.57%14.39M101.79%32.66M132.90%9.95M
Selling and administrative expenses 6.92%6.28M28.27%6.41M33.66%6.2M142.06%21.08M36.54%5.58M259.46%5.87M170.51%5M305.16%4.64M253.12%8.71M235.50%4.08M
-General and administrative expense 6.92%6.28M28.27%6.41M33.66%6.2M142.06%21.08M36.54%5.58M259.46%5.87M170.51%5M305.16%4.64M253.12%8.71M235.50%4.08M
Research and development costs 83.73%18.86M42.81%15.03M17.58%11.47M92.18%46.02M164.04%15.48M29.27%10.27M158.06%10.52M60.81%9.76M74.58%23.95M92.01%5.86M
Operating profit -55.79%-25.14M-38.13%-21.44M-22.75%-17.67M-105.48%-67.1M-111.69%-21.05M-68.53%-16.14M-161.94%-15.52M-99.57%-14.39M-101.79%-32.66M-132.90%-9.95M
Net non-operating interest income expense 52.60%2.7M52.20%2.69M-19.98%1.45M1.77M1.77M1.81M
Non-operating interest income 52.60%2.7M52.20%2.69M-19.98%1.45M----------1.77M--1.77M--1.81M--------
Other net income (expense) 101.03%1K66.46%-55K-55.29%-264K350.67%6.72M603.35%7.15M-125.73%-97K-256.19%-164K-2,025.00%-170K2,625.42%1.49M1,491.78%1.02M
Other non- operating income (expenses) 101.03%1K66.46%-55K-55.29%-264K350.67%6.72M603.35%7.15M-125.73%-97K-256.19%-164K-2,025.00%-170K2,625.42%1.49M1,491.78%1.02M
Income before tax -55.13%-22.44M-35.10%-18.8M-29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M
Income tax
Net income -55.13%-22.44M-35.10%-18.8M-29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M
Net income continuous Operations -55.13%-22.44M-35.10%-18.8M-29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M
Minority interest income
Net income attributable to the parent company -55.13%-22.44M-35.10%-18.8M-29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -55.13%-22.44M-35.10%-18.8M-29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M
Basic earnings per share 10.61%-0.5917.46%-0.52-25.86%-0.7363.76%-2.74-8.75%-0.87-34.97%-0.66-39.75%-0.63-3.71%-0.58-500.86%-7.56-137.81%-0.8
Diluted earnings per share 10.61%-0.5917.46%-0.52-25.86%-0.7363.76%-2.74-8.75%-0.87-34.97%-0.66-39.75%-0.63-3.71%-0.58-500.86%-7.56-137.81%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+11.17%
MicroStrategy
MSTR
+6.18%
Tesla
TSLA
+4.97%
Alphabet-A
GOOGL
+4.51%
Coinbase
COIN
+4.50%

Unlock the Full List